ArticleJournal of clinical neurology (Seoul, Korea)2026

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Jie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.